– USA, NJ – Castor, a leading provider of decentralized and hybrid clinical trial solutions, today announced the appointment of industry veteran Milind Kamkolkar to its Board of Directors.
“We’ve made significant progress in advancing our clinical and technology and practices this year,” said founder and CEO, Dr. Derk Arts. “We are thrilled to have Milind join our Board. His expertise, insights and passion for technology combined with the collective experience of our leadership team and Board, is critical to our ability to operationalize and achieve our vision of democratizing clinical research to maximize the impact of research data for patients worldwide.”
Milind Kamkolkar joined Cellarity from Sanofi where he was the first enterprise Chief Data Officer in the pharmaceutical industry. Before Sanofi, he was the Head of AI and Data Science within the Digital Medicines group at Novartis.
About Milind Kamkolkar
Milind Kamkolkar is currently Senior Advisor to Cellarity, a Flagship Pioneering company, after his tenure as Chief Digital & Data Officer. He brings to Castor more than 20 years of experience in healthcare AI and digital health, from startup, management consulting to Fortune 500 enterprises. As a Board member, Milind Kamkolkar will help Castor accelerate its goal of making the world’s research data more accessible, enabling AI-driven clinical trials, and ultimately using actionable data to improve the speed and efficiency of clinical trials.
“The adoption of decentralized clinical trials has seen exponential growth, catalyzing an industry in critical need of modernization,” said Milind Kamkolkar. “I was impressed by the leadership, talent, and technology at Castor, which complement the hard problems Castor’s platform tackles with technical sophistication. To support the growing clinical research needs of academic centers and life sciences companies, Castor’s technology simplifies the clinical trial process and ‘consumerizes’ new processes for tech-enabled clinical trials. I look forward to contributing my expertise and being a part of Castor’s journey to enable faster, smarter clinical trials.”
About Castor
Castor is a leading provider of decentralized and hybrid clinical trial solutions to democratize research. With the highest-rated eClinical platform for decentralized and hybrid clinical trials, Castor’s plug-and-play platform offers rapid deployment at scale, enabling researchers to create a trial in a matter of clicks, with easy enrollment, eConsent, and real-world data capture. Castor is bringing human-centered design to the clinical trial process, from recruitment to analysis, and improving the quality, security, and reusability of data for researchers worldwide.
For more information: https://www.castoredc.com/
- Disclaimer - News, data, and statements included in this release are intended exclusively for general information purposes. Talent4Boards does not guarantee that news is accurate or about the correct person and accepts neither liability for the consequences of the reader’s reliance, nor responsibility for the accuracy of the information. Nothing in this release should be considered for decisions about referred securities. Products and brand names may be trademarks or registered trademarks of their respective owners.
